GO:0004788 thiamine diphosphokinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004788 thiamine diphosphokinase activity catalyzes the reaction ATP + thiamine = AMP + thiamine diphosphate (ThDP), the essential coenzyme form of vitamin B1.
• The enzyme is conserved from yeast to humans; the yeast THI80 gene encodes a constitutive thiamine pyrophosphokinase, and thi80 mutations reduce its activity.
• ThDP is a cofactor for key metabolic enzymes including pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and transketolase.
• Defects in thiamine transport and metabolism cause severe neurological disease, including thiamine metabolism dysfunction syndrome 5 and pyruvate dehydrogenase complex deficiency.
• Thiamine analogs and inhibitors of thiamine diphosphokinase are explored as antiplasmodial and metabolic-modulating agents.
• Optimizing thiamine pyrophosphate metabolism has been linked to improved crop yield and quality, highlighting its broader biological importance.
Description
Thiamine diphosphokinase activity (GO:0004788) is a molecular function that enables the transfer of a pyrophosphate group from ATP to thiamine, producing thiamine diphosphate (ThDP) and AMP. ThDP is the biologically active form of vitamin B1 and serves as an essential cofactor for several enzymes of central carbon metabolism, including pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and transketolase. Because these enzymes link glycolysis, the tricarboxylic acid cycle, and the pentose phosphate pathway, the reaction catalyzed by thiamine diphosphokinase is a critical node in cellular energy metabolism and biosynthetic precursor supply. Researchers study this activity to understand metabolic regulation, to model thiamine-related diseases, and to develop therapeutic or agricultural interventions. The yeast Saccharomyces cerevisiae has provided a classic genetic system for this enzyme: the thi80 mutation was shown to cause reduced thiamine pyrophosphokinase activity, establishing a direct link between genotype and enzyme function. In humans, impaired thiamine metabolism and transport underlie a spectrum of neurological disorders, making the enzyme and its product ThDP important targets for mechanistic and translational research. This article summarizes the definition, mechanism, key genes, disease relevance, and experimental approaches for studying GO:0004788.
thiamine diphosphokinase activity At A Glance
| GO ID | GO:0004788 |
|---|---|
| GO term | thiamine diphosphokinase activity |
| Ontology | molecular_function |
| Definition | Catalysis of the reaction: ATP + thiamine = AMP + thiamine diphosphate. |
| Synonym | ATP:thiamine diphosphotransferase activity; ATP:thiamin pyrophosphotransferase activity; thiamin:ATP pyrophosphotransferase activity; thiamin diphosphokinase activity; thiamine pyrophosphokinase activity; thiaminokinase activity; thiamin pyrophosphokinase activity; thiamin pyrophosphotransferase activity; TPTase activity |
| Major function | Synthesis of thiamine diphosphate (ThDP), the active coenzyme form of vitamin B1. |
| Reaction | ATP + thiamine = AMP + thiamine diphosphate. |
| Cellular role | Provides ThDP for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and transketolase. |
| Representative gene | THI80 in Saccharomyces cerevisiae; human orthologs include TPK1. |
| Disease link | Thiamine metabolism dysfunction syndrome 5 and pyruvate dehydrogenase complex deficiency. |
What Is GO:0004788?
According to the Gene Ontology, GO:0004788 thiamine diphosphokinase activity is defined as the catalysis of the reaction ATP + thiamine = AMP + thiamine diphosphate. In other words, the enzyme uses ATP to phosphorylate thiamine (vitamin B1) at the diphosphate level, generating thiamine diphosphate (also called thiamine pyrophosphate, ThDP) and releasing AMP. This activity is synonymous with thiamine pyrophosphokinase activity, thiaminokinase activity, and TPTase activity, among other names. The reaction is a pyrophosphoryl transfer rather than a simple monophosphorylation, and the product ThDP is the coenzyme form required by several dehydrogenases and transketolase.
Why Is thiamine diphosphokinase activity Important in Cell Biology?
Thiamine diphosphokinase activity is important because it produces thiamine diphosphate, the coenzyme required for oxidative decarboxylation of pyruvate and alpha-ketoglutarate, branched-chain amino acid catabolism, and the non-oxidative branch of the pentose phosphate pathway. Without sufficient ThDP, cells cannot efficiently couple glycolysis to the tricarboxylic acid cycle, leading to energy failure and accumulation of lactate and other metabolites. In humans, defects in thiamine transport and metabolism cause severe neurological phenotypes, including thiamine metabolism dysfunction syndrome 5 and pyruvate dehydrogenase complex deficiency, which can present with encephalopathy, lactic acidosis, and developmental delay. In infectious disease research, thiamine analogs that interfere with thiamine metabolism have shown antiplasmodial activity, suggesting that the pathway is a potential drug target. In agriculture, optimizing thiamine pyrophosphate metabolism has been associated with enhanced crop yield and quality, indicating that this activity has broad biological and economic relevance.
• Produces thiamine diphosphate (ThDP), the essential cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and transketolase.
• Links glycolysis, the TCA cycle, and the pentose phosphate pathway, thereby supporting cellular energy production and biosynthetic reactions.
• Mutations in thiamine metabolism genes, including the yeast THI80 gene, reduce thiamine pyrophosphokinase activity and impair growth.
• Defects in thiamine transport and metabolism cause neurological disorders such as thiamine metabolism dysfunction syndrome 5 and pyruvate dehydrogenase complex deficiency.
• Thiamine analogs with antiplasmodial activity highlight the pathway as a potential target for antiparasitic drug development.
• Inhibitors such as ALT-711 can act as low-affinity inhibitors of thiamine diphosphokinase, providing chemical tools to probe the enzyme.
• Optimizing thiamine pyrophosphate metabolism has been linked to improved crop yield and quality, showing agricultural relevance.
• The enzyme is conserved across species, making yeast and human cell models useful for functional studies.
• Thiamine triphosphorylated derivatives and their metabolizing complexes are an active area of research, with implications for cellular signaling.
• Studying this activity helps interpret variants of uncertain significance in thiamine metabolism genes and guides therapeutic strategies.
Molecular Mechanism of thiamine diphosphokinase activity
Substrate binding and pyrophosphate transfer
In simple terms: The enzyme grabs ATP and thiamine and moves a pyrophosphate group from ATP onto thiamine.
Thiamine diphosphokinase binds ATP and thiamine and catalyzes the transfer of a pyrophosphate moiety from ATP to thiamine, yielding thiamine diphosphate (ThDP) and AMP. This reaction is a pyrophosphoryl transfer, distinguishing it from simple monophosphorylation, and it directly generates the coenzyme form of vitamin B1. The enzyme is conserved from yeast to humans, and the yeast THI80 gene product is a constitutive thiamine pyrophosphokinase whose activity is reduced in thi80 mutants.
Product utilization by ThDP-dependent enzymes
In simple terms: The ThDP made by this enzyme is used by other enzymes to break down sugars and amino acids.
The ThDP produced by thiamine diphosphokinase serves as an essential cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and transketolase. These enzymes participate in oxidative decarboxylation and carbon shuffling reactions that are central to energy metabolism and biosynthesis. Consequently, the activity of thiamine diphosphokinase influences flux through glycolysis, the TCA cycle, and the pentose phosphate pathway.
Cofactors and metal requirements
In simple terms: The enzyme uses ATP as the phosphate donor and does not require a metal cofactor for the basic reaction.
The defining reaction uses ATP as the pyrophosphate donor and thiamine as the acceptor, producing AMP and ThDP. The QuickGO definition does not specify a required metal ion, and the reaction is typically described as a direct pyrophosphoryl transfer. Thiamine triphosphorylated derivatives and their metabolizing complexes are related but distinct from the diphosphokinase reaction, and they are studied as part of the broader thiamine phosphate metabolism network.
Inhibition and chemical probes
In simple terms: Some drugs can block this enzyme, which helps researchers study what happens when ThDP production is reduced.
The advanced glycation end product-lowering agent ALT-711 has been identified as a low-affinity inhibitor of thiamine diphosphokinase, providing a chemical tool to modulate the enzyme. Thiamine analogs have also been characterized for their antiplasmodial activity, suggesting that interference with thiamine metabolism can have antiparasitic effects. These inhibitors and analogs are useful for probing the physiological consequences of reduced ThDP synthesis.
Regulation of thiamine metabolism
In simple terms: Cells adjust thiamine use and storage in response to demand, and the enzyme is part of that regulated network.
Thiamine metabolism is regulated at multiple levels, including transport, phosphorylation, and degradation, and defects in these processes cause disease. In yeast, the thi80 mutation causes reduced thiamine pyrophosphokinase activity, demonstrating that genetic lesions can directly affect enzyme function. In humans, variants in genes involved in thiamine transport and metabolism, including those causing thiamine metabolism dysfunction syndrome 5, alter the availability of ThDP and lead to neurological phenotypes. The broader network of thiamine triphosphorylated derivatives and their metabolizing complexes further modulates thiamine phosphate pools.
Key Genes Involved in GO:0004788 thiamine diphosphokinase activity
The following genes and proteins are directly or functionally linked to thiamine diphosphokinase activity (GO:0004788) and its product thiamine diphosphate.
| Gene | Major Role | Research Relevance |
|---|---|---|
| THI80 (S. cerevisiae) | Encodes a constitutive thiamine pyrophosphokinase; thi80 mutants show reduced activity | Classic genetic model for studying thiamine diphosphokinase function and regulation |
| TPK1 (human) | Thiamine pyrophosphokinase that catalyzes ATP + thiamine = AMP + ThDP | Candidate gene for thiamine metabolism disorders and variant interpretation |
| SLC19A2 | Thiamine transporter; affects intracellular thiamine availability for phosphorylation | Linked to thiamine-responsive megaloblastic anemia and related phenotypes |
| SLC19A3 | Thiamine transporter; mutations cause thiamine metabolism dysfunction syndrome 5 | Model for studying neurological consequences of impaired thiamine supply |
| SLC25A19 | Mitochondrial thiamine pyrophosphate carrier | Relevant to mitochondrial ThDP-dependent enzyme function |
| PDHA1 | Pyruvate dehydrogenase E1 alpha subunit; uses ThDP as cofactor | Defects cause pyruvate dehydrogenase complex deficiency |
| PDHB | Pyruvate dehydrogenase E1 beta subunit; ThDP-dependent | Component of PDH complex; relevant to ThDP-dependent metabolism |
| DLD | Dihydrolipoamide dehydrogenase; part of PDH and KGDH complexes | Links ThDP-dependent complexes to oxidative metabolism |
| OGDH | Alpha-ketoglutarate dehydrogenase; ThDP-dependent | TCA cycle enzyme requiring ThDP |
| BCKDHA | Branched-chain alpha-ketoacid dehydrogenase E1 alpha; ThDP-dependent | Branched-chain amino acid catabolism |
| TKT | Transketolase; ThDP-dependent enzyme of pentose phosphate pathway | Links ThDP to NADPH production and ribose synthesis |
| TPK1 (yeast ortholog) | Thiamine pyrophosphokinase activity | Conserved function across species |
| THTPA | Thiamine triphosphatase; related to thiamine phosphate metabolism | Part of the broader thiamine derivative network |
| ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase; can hydrolyze thiamine derivatives | Modulates extracellular thiamine phosphate pools |
| SLC22A1 | Organic cation transporter; may influence thiamine uptake | Potential modifier of intracellular thiamine levels |
| SLC22A2 | Organic cation transporter; may influence thiamine uptake | Potential modifier of intracellular thiamine levels |
| SLC22A3 | Organic cation transporter; may influence thiamine uptake | Potential modifier of intracellular thiamine levels |
| ALDH7A1 | Aldehyde dehydrogenase; not directly ThDP-dependent but linked to vitamin B1 metabolism | Relevant to pyridoxine-dependent epilepsy and thiamine interplay |
How Is thiamine diphosphokinase activity Regulated?
Thiamine diphosphokinase activity is regulated by the availability of its substrates, ATP and thiamine, and by the expression and activity of thiamine transporters and metabolic enzymes. In yeast, the thi80 mutation reduces thiamine pyrophosphokinase activity, showing that genetic regulation of the enzyme directly affects thiamine metabolism. In humans, defects in thiamine transport and metabolism alter ThDP levels and cause disease, indicating that the pathway is under tight physiological control. The broader network of thiamine triphosphorylated derivatives and their metabolizing complexes also contributes to the regulation of thiamine phosphate pools. Additionally, chemical inhibitors such as ALT-711 can modulate enzyme activity, providing a pharmacological handle on the pathway.
thiamine diphosphokinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC19A3 | Thiamine metabolism dysfunction syndrome 5 | Knockout or point-mutation cell models to study thiamine transport and ThDP levels |
| PDHA1 | Pyruvate dehydrogenase complex deficiency | Knock-in of patient variants to assess PDH function and ThDP dependence |
| TPK1 | Thiamine metabolism disorder (candidate) | Knockout and overexpression models to measure thiamine diphosphokinase activity |
| THI80 (yeast) | Reduced thiamine pyrophosphokinase activity | Yeast thi80 mutants as a model for enzyme function |
| SLC19A2 | Thiamine-responsive megaloblastic anemia | Knockout cell lines to study thiamine uptake and phosphorylation |
Thiamine metabolism dysfunction syndrome 5
Thiamine metabolism dysfunction syndrome 5 is a severe neurological disorder caused by defects in thiamine metabolism, including impaired transport and phosphorylation. Patients can present with encephalopathy, lactic acidosis, and developmental delay, and treatment with thiamine or its derivatives may improve outcomes. The wide phenotypic spectrum highlights the importance of early diagnosis and the role of ThDP synthesis in brain metabolism.
Pyruvate dehydrogenase complex deficiency
Pyruvate dehydrogenase complex deficiency is caused by mutations in genes encoding PDH components, which require thiamine diphosphate as a cofactor. Novel synonymous and deep intronic variants have been identified in patients with primary and secondary PDH deficiency, expanding the mutational spectrum. Because PDH links glycolysis to the TCA cycle, its dysfunction leads to lactic acidosis and neurological impairment.
Thiamine transport and metabolism defects
Defects of thiamine transport and metabolism cause a range of clinical phenotypes, including thiamine-responsive megaloblastic anemia and neurological disorders. These conditions underscore the importance of thiamine diphosphokinase activity in maintaining cellular ThDP levels. Genetic and biochemical studies of transporters and enzymes in this pathway inform diagnosis and treatment strategies.
Infectious disease and drug discovery
Thiamine analogs with antiplasmodial activity have been identified, suggesting that targeting thiamine metabolism, including thiamine diphosphokinase, could be a strategy against Plasmodium species. The enzyme is also inhibited by compounds such as ALT-711, which can be used to probe the consequences of reduced ThDP synthesis. These findings support further investigation of thiamine metabolism as a therapeutic target.
From thiamine diphosphokinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of thiamine diphosphokinase reduce ThDP levels and affect metabolism? | CRISPR knockout of TPK1 or THI80 in cell lines or yeast |
| Do patient variants in thiamine metabolism genes alter enzyme function? | Point-mutation knock-in of SLC19A3 or PDHA1 variants |
| Can tagged enzyme be used to study localization and interactions? | Knock-in of fluorescent or affinity tags at the endogenous locus |
| Does overexpression of thiamine transporters increase ThDP synthesis? | Overexpression of SLC19A2 or SLC19A3 in cell models |
| What are the metabolic consequences of enzyme inhibition? | Treatment with ALT-711 or thiamine analogs in wild-type and knockout cells |
| Can thiamine metabolism be optimized for crop traits? | Plant models with modified thiamine pyrophosphate metabolism |
How to Study the thiamine diphosphokinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic activity assay | Thiamine diphosphokinase activity | Validate variants and inhibitors |
| LC-MS metabolomics | Thiamine phosphate levels including ThDP | Assess pathway flux in cells and tissues |
| CRISPR knockout screening | Gene essentiality and modifiers of thiamine dependence | Identify novel regulators of thiamine metabolism |
| RNA-seq | Expression of thiamine transporters and ThDP-dependent enzymes | Study transcriptional adaptation |
| Proteomics | Protein abundance and interactions | Map thiamine metabolism complexes |
| Yeast genetics | Thiamine pyrophosphokinase function in vivo | Model thi80 mutations |
| Inhibitor profiling | Sensitivity to ALT-711 or thiamine analogs | Chemical biology of thiamine metabolism |
| Fluorescence imaging | Localization of tagged enzymes | Study subcellular distribution |
Enzymatic activity assays
Thiamine diphosphokinase activity can be measured by monitoring the conversion of thiamine and ATP to ThDP and AMP using coupled enzymatic or chromatographic methods. Yeast thi80 mutants provide a genetic background to validate activity changes. These assays are essential for confirming the functional impact of variants and inhibitors.
Metabolomics and ThDP quantification
Quantification of thiamine phosphates, including ThDP, by LC-MS or HPLC allows direct assessment of pathway flux. Such methods can reveal how genetic or pharmacological perturbations affect thiamine metabolism. Metabolomics also helps link thiamine diphosphokinase activity to downstream metabolic pathways.
Genetic and CRISPR screens
CRISPR knockout and knock-in screens can identify genes that modify thiamine dependence or ThDP levels. Yeast genetics, including thi80 mutants, offers a complementary system for pathway dissection. These approaches can uncover synthetic lethal interactions and compensatory mechanisms.
Transcriptomics and proteomics
RNA-seq and proteomics can measure expression changes in thiamine transporters and ThDP-dependent enzymes under different conditions. Such data help interpret how cells adapt to altered thiamine metabolism. Integrating multi-omics with functional assays provides a systems view of the pathway.
How CRISPR Can Be Used to Study GO:0004788 thiamine diphosphokinase activity
Knockout
CRISPR knockout of TPK1 or its orthologs can abolish thiamine diphosphokinase activity, leading to reduced ThDP levels and impaired function of ThDP-dependent enzymes. Such models are useful for studying the consequences of thiamine metabolism defects and for validating drug targets. Yeast thi80 knockouts provide a complementary system with well-characterized phenotypes.
Point Mutation
Point-mutation knock-in can recreate patient variants in genes such as SLC19A3 or PDHA1 to assess their impact on thiamine metabolism and enzyme function. These models help distinguish pathogenic from benign variants and reveal genotype-phenotype relationships. They are also valuable for testing thiamine supplementation as a therapeutic strategy.
Knock-in
Knock-in of tags or reporters at the endogenous TPK1 locus allows real-time monitoring of enzyme expression and localization. This approach can be combined with metabolic assays to correlate enzyme levels with ThDP production. Tagged knock-in models are also useful for interaction proteomics.
Overexpression
Overexpression of thiamine transporters or thiamine diphosphokinase can increase ThDP synthesis and modulate metabolic flux. Such models are useful for studying the effects of enhanced thiamine metabolism on cell growth and stress resistance. They can also serve as positive controls in activity assays.
How EDITGENE Supports thiamine diphosphokinase activity Research
Researchers studying thiamine diphosphokinase activity-related genes often need to determine whether a candidate gene is causally involved in thiamine metabolism, neurological disease, or metabolic adaptation. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly in relevant cellular systems.
Contact EDITGENE today to design your custom CRISPR model for thiamine diphosphokinase activity research.
Frequently Asked Questions About thiamine diphosphokinase activity
What is thiamine diphosphokinase activity?
Thiamine diphosphokinase activity (GO:0004788) is the catalysis of the reaction ATP + thiamine = AMP + thiamine diphosphate, producing the active coenzyme form of vitamin B1.
What genes are involved in thiamine diphosphokinase activity?
Key genes include THI80 in yeast and TPK1 in humans, as well as thiamine transporters such as SLC19A2 and SLC19A3 that supply thiamine for phosphorylation.
What is the reaction catalyzed by thiamine diphosphokinase?
The enzyme transfers a pyrophosphate group from ATP to thiamine, yielding thiamine diphosphate and AMP.
Why is thiamine diphosphate important?
Thiamine diphosphate is an essential cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and transketolase.
What diseases are linked to thiamine metabolism defects?
Thiamine metabolism dysfunction syndrome 5 and pyruvate dehydrogenase complex deficiency are among the disorders caused by defects in thiamine transport and metabolism.
Can thiamine diphosphokinase be inhibited?
Yes, compounds such as ALT-711 have been identified as low-affinity inhibitors of thiamine diphosphokinase, and thiamine analogs show antiplasmodial activity.
How is thiamine diphosphokinase activity measured?
Activity can be measured by enzymatic assays that monitor the conversion of thiamine and ATP to ThDP and AMP, often coupled with LC-MS or HPLC quantification.
What model systems are used to study thiamine metabolism?
Yeast thi80 mutants, human cell lines with CRISPR knockouts or knock-ins, and animal models are commonly used.
Is thiamine diphosphokinase conserved across species?
Yes, the enzyme is conserved from yeast to humans, with THI80 in Saccharomyces cerevisiae and TPK1 in humans.
How does thiamine metabolism affect crop yield?
Optimizing thiamine pyrophosphate metabolism has been associated with improved crop yield and quality, indicating agricultural relevance.
Conclusion
Thiamine diphosphokinase activity (GO:0004788) is a central molecular function that generates thiamine diphosphate, the coenzyme required for key metabolic enzymes and neurological health. Genetic studies in yeast and humans have linked this activity to thiamine metabolism disorders and pyruvate dehydrogenase complex deficiency, while chemical inhibitors and analogs provide tools for therapeutic exploration. Continued research using CRISPR models, metabolomics, and multi-omics approaches will clarify how thiamine diphosphokinase is regulated and how its dysfunction contributes to disease.
References
- 1. Luo Y et al.. 2025. Optimizing thiamine pyrophosphate metabolism enhances crop yield and quality.. Nat Commun 17(1):165 PMID: 41318547
- 2. Fathoni I et al.. 2024. Identification and characterization of thiamine analogs with antiplasmodial activity.. Antimicrob Agents Chemother 68(12):e0109624 PMID: 39470204
- 3. Bruhn H et al.. 2024. Novel Synonymous and Deep Intronic Variants Causing Primary and Secondary Pyruvate Dehydrogenase Complex Deficiency.. Hum Mutat 2024:1611838 PMID: 40225937
- 4. Brown G. 2014. Defects of thiamine transport and metabolism.. J Inherit Metab Dis 37(4):577-85 PMID: 24789339
- 5. Dallan A et al.. 2025. The wide phenotypic spectrum of thiamine metabolism dysfunction syndrome 5 and its treatment.. Orphanet J Rare Dis 20(1):160 PMID: 40186230
- 6. Nishimura H et al.. 1991. A constitutive thiamine metabolism mutation, thi80, causing reduced thiamine pyrophosphokinase activity in Saccharomyces cerevisiae.. J Bacteriol 173(8):2716-9 PMID: 1849514
- 7. Bettendorff L. 2021. Update on Thiamine Triphosphorylated Derivatives and Metabolizing Enzymatic Complexes.. Biomolecules 11(11) PMID: 34827643
- 8. Krautwald M et al.. 2011. The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase.. Rejuvenation Res 14(4):383-91 PMID: 21612515
